Colorectal Cancer (CRC) Recruiting Phase Trials for Irinotecan (DB00762)

Also known as: Malignant Neoplasm of Colorectum / CRC, Colorectal Cancer / Colorectal Cancer / Cancer, Colorectal / CRC (Colorectal Cancer) / Colorectal, Cancer / Colo-rectal Cancer / Colorectal Cancers / A. Colorectal Cancer / Cancer Colorectal / Gastrointestinal Cancers - Colorectal / CRC / CRCS / Malignant colorectal neoplasm / Malignant neoplasm of cecum and/or colon and/or rectum / Malignant neoplasm of caecum and/or colon and/or rectum / Malignant neoplasm of cecum and/or colon and/or rectum (disorder) / Malignant neoplasm of large intestine / Malignant tumor of large intestine / Malignant tumour of large intestine / Malignant neoplasm of large intestine (disorder) / Malignant neoplasm of colon, unspecified / Malignant large intestinal neoplasm NOS / Cancer of large intestine / Malignant neoplasm of large intestine, NOS / Cancer of large bowel / CA - Cancer of large bowel / Colorectal neoplasms malignant / Malignant neoplasm of colon and/or rectum (disorder) / Large intestine carcinoma / Colorectal carcinoma / Colorectal cancer NOS

IndicationStatusPhase
DBCOND0031867 (Colorectal Cancer (CRC))RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT07044362
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver MetastasisSupportive Care
NCT06443307
Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan
NCT05391126
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual CareTreatment